High-throughput antibody screening, run to a standard your data can stand on.
We partner with pharma, biotech, and academic research groups to run high-throughput antibody screening campaigns — from sample intake to analysis-ready data.
High-throughput screening, built for rigor
Every study runs on validated protocols with full batch tracking, whether it’s headed for a lab notebook or a regulatory file.
Antibody High-Throughput Screening
We use droplet microfluidic technology to encapsulate single cells or antibody candidates together with antigen-conjugated beads, then read and sort each droplet by fluorescence signal. Because every droplet is its own isolated micro-reactor, we can detect secreted and intracellular targets that surface-only methods like flow cytometry miss. Sorting uses ultra-low dielectrophoretic force to keep cells viable for downstream culture, and every run is UV-sterilized between samples to rule out cross-contamination.
Learn moreSix advantages built into the platform
Shorten the R&D Cycle
High-throughput screening of plasma B cell repertoires within a 24-hour workflow — dramatically shortening the timeline from sample to hit list.
Cost-Effective
Picoliter-scale droplets cut reagent consumption by more than 90% per sample versus conventional screening. Droplet volumes also run generally smaller than the reaction chambers used in comparable chip-based optofluidic systems, which tends to keep per-sample reagent costs lower there too.
High Scalability
Optional droplet fusion modules extend the platform to more complex assay designs as your screening program grows.
Ultra Sensitivity
Nanomolar-level detection captures signal from rare biomarkers and low-frequency positives that conventional systems miss.
High Compatibility
Integrates with industry-standard detection reagents and adapts its workflow configuration to your lab’s existing protocols.
Flexible Recovery
Recover sorted droplets as a bulk collection or dispense precisely into 96- or 384-well plates, built to hand off directly into your downstream workflow.
Built for teams who need to trust the data
Throughput Without Shortcuts
Our droplet platform generates up to 10,000 droplets per second and screens more than a million B cells per run — without compromising assay controls or replicate structure.
Publication- and Regulatory-Ready Data
Every dataset ships with full QC documentation — built to hold up in peer review as readily as in an internal decision.
Confidential by Default
NDA-first engagement, secure data transfer, and a dedicated project lead assigned to every study.
From sample to dataset in four steps
Consult & Design
Define your assay panel and screening strategy together with our scientific team.
Sample Submission
Ship samples under our intake protocol; we confirm quality on arrival before the run starts.
Screening
Your campaign runs on our droplet microfluidic platform — generation, fluorescence reading, and sorting in one automated workflow, with full batch and replicate tracking.
Data Delivery
Receive analysis-ready data, QC reports, and a debrief call with our team.
Located in one of Europe’s densest life science research clusters, we work with academic groups and industry partners across Europe.
Ready to scope your next study?
Tell us about your screening panel — we’ll come back with a study design and quote.
Request a Quote